Alliance Pharma Plc (APH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | -3,731 | -15,664 | 4,272 | 10,838 | 4,989 |
| Accounts receivable | 5,422 | -6,481 | -18,720 | -6,146 | 6,728 |
| Other Working Capital | 3,912 | -14,188 | -14,726 | 4,839 | 7,451 |
| Other Operating Activity | 33,113 | 67,743 | 50,146 | 29,128 | 22,399 |
| Operating Cash Flow | $38,716 | $31,410 | $20,972 | $38,659 | $41,567 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -841 | -696 | -358 | -1,526 | -4,612 |
| Net Acquisitions | 0 | -222 | -16,618 | 183 | -82,667 |
| Purchase Sale Intangibles | 2,835 | 0 | -249 | -3,256 | 1,405 |
| Other Investing Activity | 2,897 | 0 | 200 | 750 | 1,415 |
| Investing Cash Flow | $2,056 | $-918 | $-17,025 | $-4,599 | $-85,864 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 14,925 | 0 | 82,595 |
| Debt Repayment | -21,235 | -18,000 | -1,261 | -22,587 | -21,541 |
| Common Stock Issued | 21 | 37 | 341 | 736 | 1,644 |
| Dividend Paid | N/A | -9,592 | -9,116 | -8,604 | -2,837 |
| Other Financing Activity | -9,670 | -11,638 | -5,765 | -3,889 | -4,112 |
| Financing Cash Flow | $-30,884 | $-39,193 | $-876 | $-34,344 | $55,749 |
| Exchange Rate Effect | 36 | -577 | -418 | 447 | -384 |
| Beginning Cash Position | 22,436 | 31,714 | 29,061 | 28,898 | 17,830 |
| End Cash Position | 32,360 | 22,436 | 31,714 | 29,061 | 28,898 |
| Net Cash Flow | $9,888 | $-8,701 | $3,071 | $-284 | $11,452 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,716 | 31,410 | 20,972 | 38,659 | 41,567 |
| Capital Expenditure | -841 | -696 | -607 | -5,532 | -4,612 |
| Free Cash Flow | 37,875 | 30,714 | 20,365 | 33,127 | 36,955 |